A systematic review of persistence and compliance with bisphosphonates for osteoporosis

被引:0
作者
J. A. Cramer
D. T. Gold
S. L. Silverman
E. M. Lewiecki
机构
[1] Yale University School of Medicine,Department of Psychiatry
[2] Duke University Medical Center,Cedars
[3] UCLA,Sinai Medical Center
[4] New Mexico Clinical Research and Osteoporosis Center,undefined
来源
Osteoporosis International | 2007年 / 18卷
关键词
Bisphosphonates; Compliance; Database; Medication possession ratio; Osteoporosis; Persistence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1023 / 1031
页数:8
相关论文
共 91 条
[1]  
Woolf AD(2003)Burden of major musculoskeletal conditions Bull World Health Organ 81 646-656
[2]  
Pfleger B(2000)Quantitative ultrasound: an indicator of osteoporosis in perimenopausal women J Clin Densitom 3 141-147
[3]  
Nairus J(2001)Changes in QUS and BMD measurements with antiresorptive therapy: a two-year longitudinal study Calcif Tissue Int 69 138-146
[4]  
Ahmadi S(2001)Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis J Bone Miner Res 16 406-416
[5]  
Baker S(1998)Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites J Clin Densitom 1 5-11
[6]  
Frost ML(1995)How many women have osteoporosis now? J Bone Miner Res 10 175-177
[7]  
Blake GM(2004)Compliance with drug therapies for the treatment and prevention of osteoporosis Maturitas 48 271-287
[8]  
Frost ML(2004)The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003-1008
[9]  
Blake GM(2003)Compliance with pharmacologic therapy for osteoporosis Osteoporos Int 14 965-968
[10]  
Fogelman I(2006)Determinants of adherence to osteoporosis treatment in clinical practice Osteoporos Int 17 914-921